press releases rule

Archives: Search / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

Aug 19, 2014
-- Two of Company's Anti-Infective Programs to be Presented at Highly Regarded Scientific Conference: Pertussis and C. difficile --
Aug 14, 2014
-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C. difficile and C-IBS Programs into the Clinic During 2014 --
Aug 13, 2014
-- Keynote Speaker: Mark Pimentel, M.D., FRCP©, Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board --
Aug 12, 2014
-- SYN-005 Program Targeting Pertussis Toxin to be Highlighted in Oral Presentation --
Aug 7, 2014
-- Conference Call Scheduled for Thursday, August 14, 2014, at 8:30 am EDT --
 

Print Email RSS